Pocket cardiology

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Preventing and managing CVD requires a multifaceted approach that addresses risk factors such as smoking, inactivity, poor diet, and hypertension. Personalized approaches such as pharmacogenomics have the potential to improve efficacy and safety of CVD medications, reduce the burden of adverse events and optimize patient outcomes. This chapter provides evidence-based recommendation for medication selection and dosing based on pharmacogenomic data. It also explores the current evidence base for lifestyle precision medicine and prevention of cardiac arrhythmia.

Original languageEnglish (US)
Title of host publicationComprehensive Precision Medicine, First Edition, Volume 1-2
PublisherElsevier
PagesV2-436-V2-442
Volume1-2
ISBN (Electronic)9780128240106
DOIs
StatePublished - Jan 1 2023

Keywords

  • Anticoagulation
  • Beta blockers
  • Clinical decision support
  • Clopidogrel
  • Drug induced arrhythmias
  • Familial cardiac arrhythmias
  • Lifestyle precision medicine
  • Long QT
  • Pharmacogenomics
  • Statin therapy

ASJC Scopus subject areas

  • General Agricultural and Biological Sciences
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Pocket cardiology'. Together they form a unique fingerprint.

Cite this